| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/05/2006 | US20060003334 Protein (poly)peptides libraries |
| 01/05/2006 | US20060002993 Genetic engineered protein; transgenic animal, used to elicit a humoral or cellular immune response |
| 01/05/2006 | US20060002948 Polypeptide isolated from Dermatophagoides; use of polypeptides, polynucleotides and/or antibodies in therapy and diagnosis of allergic disorders; genetic engineering |
| 01/05/2006 | US20060002945 Non-sensitive antigenic peptide derived from fc portion of the epsilon heavy chain of immunoglobulin-E for use in treatment and prevention of allergic disorders |
| 01/05/2006 | US20060002943 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 01/05/2006 | US20060002939 Monoclonal and chimeric antibodies that bind to lipoteichoic acid of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal; light and heavy chains comprising complementarity determining regions |
| 01/05/2006 | US20060002931 Antibodies of angiogenesis inhibiting domains CD148 |
| 01/05/2006 | US20060002926 isolated and/or recombinant; characterized by high affinity binding of one or more chemokines, such as eotaxin, RANTES and/or MCP-3, and/or the ability to stimulate a (one or more) cellular response(s) (e.g., chemotaxis, exocytosis, release of one or more inflammatory mediators) |
| 01/05/2006 | US20060002923 Recombinant anti-osteopontin antibody and use thereof |
| 01/05/2006 | US20060002904 Receptor and related products and methods |
| 01/05/2006 | US20060002892 Lectin-like transcript (LLTI); Natural killer cells; antitumor agents; quantitative analysis; human lectin transcription factor |
| 01/05/2006 | US20060000758 Reacting an inorganic support with acetoxy alkyltriethoxysilane and a linker; reacting the linker with a catalyst; reducing non-specific binding to an inorganic support; high activity, selectivity, easily recovered from reaction solutions for subsequent reuse |
| 01/05/2006 | CA2570823A1 Interferon alpha receptor 1 antibodies and their uses |
| 01/05/2006 | CA2549830A1 Selective incorporation of 5-hyroxytryptophan into proteins in mammalian cells |
| 01/04/2006 | EP1612272A2 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 01/04/2006 | EP1612268A1 Receptor ligand VEGF-C |
| 01/04/2006 | EP1612266A2 Prostaglandin reductase |
| 01/04/2006 | EP1612263A1 PTH receptor and screening assay utilizing the same |
| 01/04/2006 | EP1611887A2 Modulation of peroxisome proliferator-activated receptors |
| 01/04/2006 | EP1611156A2 Neoplasm specific antibodies and uses thereof |
| 01/04/2006 | EP1610802A2 Parkin interacting polypeptides and methods of use |
| 01/04/2006 | EP1610757A2 Profiling conformational variants, antibody compositions and methods of using the same |
| 01/04/2006 | EP1357941B1 Therapeutical use of anti-mag antibody for the treatment of ischemic stroke |
| 01/04/2006 | EP1311677B1 Regulation of human p2y1-like g protein-coupled receptor |
| 01/04/2006 | EP0970243B1 Diagnosis and treatment of glaucoma |
| 01/04/2006 | EP0923606B1 Antigenic fusionprotein carrying galalpha1,3gal epitopes |
| 01/04/2006 | EP0913405B1 Monoclonal antibody specific for prostaglandin d synthetase |
| 01/04/2006 | EP0673422B1 Cells with altered betaine catabolism, their preparation and their use, in particular for producing metabolites or enzymes |
| 01/04/2006 | CN1717483A Human artificial chromosome (HAC) vector |
| 01/04/2006 | CN1234728C Novel human lymphokine, its coding sequence and use |
| 01/04/2006 | CN1234726C Nucleic acid sequence, expression carrier and application of steady wheat high molecular gluten Dtx1.5 subunit coding gene |
| 01/04/2006 | CN1234725C High performance quick purifying method for preparing piecewise antibody |
| 01/04/2006 | CN1234720C Detection systems for registering protein interactions and functional relationships |
| 01/04/2006 | CN1234424C Collagen based composite sponge and production thereof |
| 01/03/2006 | US6982322 Monoclonal antibodies against human apoptosis inhibitory protein naip and method for assaying naip |
| 01/03/2006 | US6982320 Cytokine receptor common gamma chain like |
| 01/03/2006 | US6982319 Protein for use in the treatment of liver disorders, fibrosis, cancer, rheumatoid arthritis and glomeronephritis |
| 01/03/2006 | US6982318 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 01/03/2006 | US6982247 isolated peptide or protein of given sequence derived from the mucus of the foot sole of Archachatina marginata, a West-African snail; use against viral, bacterial or fungal infections |
| 01/03/2006 | US6982164 preferred derivatives comprise a mixture of amino acids, peptides and/or protein fractions derived from the extraction and optional hydrolysis of naturally occurring jojoba protein; use in cosmetics and as extenders |
| 01/03/2006 | US6982163 Process for preparing beta-fructofuranosidase enzyme and a process for producing fructooligosaccharides |
| 01/03/2006 | US6982162 Genetically engineered microorgaism for use as diagnostic tool |
| 01/03/2006 | US6982159 Trichoderma β-glucosidase |
| 01/03/2006 | US6982154 Modified annexin proteins and methods for treating vaso-occlusive sickle-cell disease |
| 01/03/2006 | US6982153 DNA sequences from staphylococcus aureus bacteriophage 77 that encode anti-microbial polypeptides |
| 01/03/2006 | US6982150 System and method for identifying proteins involved in force-initiated signal transduction |
| 01/03/2006 | CA2158937C Recombinant alphavirus vectors |
| 01/03/2006 | CA2070979C Sequence specific dna binding by p53 |
| 01/01/2006 | CA2502425A1 Allergen from house-dust mites |
| 12/29/2005 | WO2005123937A2 Methods for expressing rnp particles in eukaryotic cells |
| 12/29/2005 | WO2005123936A1 Method of synthesizing polypeptide |
| 12/29/2005 | WO2005123935A1 Method of producing therapeutically useful product and system |
| 12/29/2005 | WO2005123914A1 Improved methods of producing heterologous proteases |
| 12/29/2005 | WO2005123906A1 Method of increasing amount of insulin secreted and/or produced by insulin-producing cell |
| 12/29/2005 | WO2005123899A1 Fermentation process using faba beans as notrogen source |
| 12/29/2005 | WO2005123766A2 Methods of making nanotechnological and macromolecular biomimetic structures |
| 12/29/2005 | WO2005123765A1 Process for producing active wnt proteins in prokaryotes |
| 12/29/2005 | WO2005123119A2 Administration of neutral endopeptidase to treat inflammatory bowel disease |
| 12/29/2005 | WO2005122675A2 Optimized recognition site of the alphavirus non-structural protease for tag removal and specific processing of recombinant proetins |
| 12/29/2005 | WO2005074436A3 Self-assembling split-fluorescent protein systems |
| 12/29/2005 | WO2005072092A3 Systems for tightly regulated gene expression |
| 12/29/2005 | WO2005058244A3 Novel anti-dc-sign antibodies |
| 12/29/2005 | WO2005053516A3 Replication competent hepatitis c virus and methods of use |
| 12/29/2005 | WO2005043119A3 Methods and compositions for the identification of anti-poxvirus agents |
| 12/29/2005 | WO2005023996A3 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-β PROTEINS (TGF-βs) IN CELLS |
| 12/29/2005 | WO2005002359A3 Modified starch, uses, methods for production thereof |
| 12/29/2005 | WO2004069166A3 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 12/29/2005 | WO2002099040A3 Igs as modifiers of the p53 pathway and methods of use |
| 12/29/2005 | US20050289664 Genes encoding 4-Hydroxyphenylpyruvate dioxygenase (HPPD) enzymes for plant metabolic engineering |
| 12/29/2005 | US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 12/29/2005 | US20050288952 Official documents and methods of issuance |
| 12/29/2005 | US20050288487 Human mast cell-expressed membrane proteins |
| 12/29/2005 | US20050288248 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 12/29/2005 | US20050288220 Erythropoietin with high specific activity |
| 12/29/2005 | US20050288214 Nucleotide sequence encoding PTD and CEA fusion protein, Tat-CEA fusion protein, anti-tumor vaccine and pharmaceutical composition for treating tumor comprising the fusion protein |
| 12/29/2005 | US20050287648 Protein Transducing Domain/Deaminase Chimeric Proteins, Related Compounds, and Uses Thereof |
| 12/29/2005 | US20050287644 Methods for producing and culturing rabbit-mouse hybridomas and monoclonal antibodies secreted by rabbit-mouse hybridomas |
| 12/29/2005 | US20050287643 Protein binding miniature proteins and uses thereof |
| 12/29/2005 | US20050287642 Efficient protein expression system |
| 12/29/2005 | US20050287641 Gene encoding a nonribosomal peptide synthetase for the production of ramoplanin |
| 12/29/2005 | US20050287639 Methods of incorporating amino acid analogs into proteins |
| 12/29/2005 | US20050287637 Engineering intracellular sialylation pathways |
| 12/29/2005 | US20050287635 RTD receptor |
| 12/29/2005 | US20050287634 Anti-cancer agent |
| 12/29/2005 | US20050287633 Vanilloid receptor |
| 12/29/2005 | US20050287632 form a carboxyl-terminal amide of a desired peptide comprising contacting a substrate polypeptide and a palladium complex, where the palladium complex is a palladium(II) or palladium(IV) complex |
| 12/29/2005 | US20050287630 Human antibodies derived from immunized xenomice |
| 12/29/2005 | US20050287628 System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 12/29/2005 | US20050287627 In presence of ATP and peptidases |
| 12/29/2005 | US20050287626 Process for producing dipeptides |
| 12/29/2005 | US20050287625 Process for expression of foreign genes in methylotrophic bacteria through chromosomal integration |
| 12/29/2005 | US20050287595 obtaining a sample from a patient; conducting mass spectrometric analysis on the sample in a manner effective to maximize analysis of peptide fragments contained therein and comparing mass spectrum profiles of biopolymer marker and sample peptide |
| 12/29/2005 | US20050287588 Breast cancer specific gene 1 |
| 12/29/2005 | US20050287584 Secreted proteins encoded by human chromosome 13 |
| 12/29/2005 | US20050287545 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| 12/29/2005 | US20050287538 Preparing a clone for producing an antigen-specific antibody by extracting genomic DNAs of lymphocytes from a mammalian immunized with a specific antigen; recovering variable regions of immunoglobulin, amplifying the variable regions using a frame-shifting PCR |
| 12/29/2005 | US20050287530 TCL-1b gene and protein and related methods and compositions |
| 12/29/2005 | US20050287529 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 12/29/2005 | US20050287525 bioassay for testing peptides that bind to domain peptides of human immunodeficiency virus type I (HIV-1); peptides used for treating viral diseases |
| 12/29/2005 | US20050287521 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof |